CHPI Milan 2024

Hall / Stall No:2B90

Date:October 8, 2024 - October 10, 2024

Venue:FIERA MILANO, Strada Statale Sempione, 28, 20017 Rho Milan, 08908 Italy

WBCIL at CPHI Milan 2024

CPHI Milan 2024: The Premier Global Pharma Event

CPHI Milan is one of the most significant events in the global pharmaceutical industry, attracting key players from across the globe. Held from October 15-17, 2024, in Fiera Milano, Italy, the event provides a platform for professionals, manufacturers, suppliers, and innovators to connect and explore the latest developments in pharmaceuticals. Known as the heart of the global pharma sector, CPHI Milano fosters business growth, promotes cutting-edge innovations, and enables networking at an international level.

The event caters to a broad range of sectors, including Active Pharmaceutical Ingredients (APIs), formulations, biopharma, and contract services. Attendees gain invaluable insights into emerging trends, technologies, and regulatory changes affecting the industry.

Key Highlights of CPHI Milan 2024

Global Networking: With thousands of attendees and hundreds of exhibitors, CPHI Milan offers unparalleled opportunities for businesses to connect and collaborate with international partners.
Innovative Product Showcases: Companies from all over the world will showcase their latest pharmaceutical products and technologies, including APIs, drug delivery systems, and sustainable manufacturing solutions.
Industry Insights and Conferences: The event will host expert-led discussions, seminars, and presentations on pressing industry issues like sustainability, supply chain resilience, digital transformation, and regulatory compliance.
Partnering and Collaboration Opportunities: Through its CPHI worldwide 2024 as well as CPHI Milano Connect platform, the event facilitates meetings and partnerships, helping to foster long-term business relationships within the global pharmaceutical supply chain.

WBCIL’s Participation in CPHI Milan 2024

West Bengal Chemical Industries Limited (WBCIL), we, are proud to announce its participation in CPHI Milan 2024 once again, continuing its legacy as a trusted leader in the pharmaceutical and chemical industries. With a focus on delivering high-quality Active Pharmaceutical Ingredients (APIs) and other essential chemical products, we will be showcasing its commitment to innovation, sustainability, and excellence at the event.

At CPHI Milan, WBCIL team aims to highlight its cutting-edge API manufacturing capabilities, designed to meet the ever-growing needs of the global pharma market. Visitors can learn about WBCIL’s expertise in delivering high-quality, cost-effective APIs like iron and calcium salts for pharmaceutical companies worldwide.

Here we will show:

Our latest Iron and Calcium APIs, including Liposomal Iron, Ferrous Ascorbate, Ferric Carboxymaltose, Ferric Ammonium Citrate, Ferric Citrate, Iron Isomaltoside, Ferrous Asparto Glycinate, Calcium Orotate, Calcium Pidolate, Calcium Citrate Malate, Ferric Pyrophosphate, and more.

Innovative drug formulations and advanced delivery systems.
Cutting-edge quality control and assurance methodologies.
Sustainable and eco-friendly packaging solutions.
Insights into key pharma trends for 2024.
Our role in the global pharmaceutical supply chain.

New Trends in the Pharma and Chemical Industry at CPHI Milan 2024

One of the major themes at CPHI Milan 2024 will be the continued evolution of sustainability in pharmaceutical manufacturing. Companies are increasingly adopting eco-friendly production methods to minimize waste and energy consumption.

Furthermore, there will be discussions on regulatory changes impacting the industry, including shifts in compliance and quality standards that affect global pharmaceutical production and distribution.

Overall, CPHI Italy 2024 promises to be some event rich in opportunities to explore the future of the pharmaceutical and chemical industries.

Visit us to discover potential collaborations, explore our latest innovations at CPHI Milano 2024, and discuss how WBCIL can meet your pharmaceutical needs in Europe and beyond.